News

Select Category
Tuesday 25th January 2011

New venture receives investment from the Mercia Fund

Description
The Native Antigen Company (NAC) has been formed following a spin-out from PsiOxus, formerly Hybrid BioSystems, itself a university of Birmingham Spin-out.
Date:
Tuesday 25th January 2011
Categories:
Alumni, Medical and Dental Sciences, Research
Thursday 6th January 2011

Enterprising Birmingham Competition Announces finalists

Description
Enterprising Birmingham, The University of Birmingham's new Business Plan Competition
Date:
Thursday 6th January 2011
Categories:
Alumni, Corporate Services, Research, Students
Wednesday 15th December 2010

University of Birmingham vaccine technology is rising star in new biotech company

Description
University of Birmingham spin-out company, Hybrid BioSystems, Ltd. (Hybrid), and Myotec Therapeutics, Ltd. (Myotec) today announced their merger to form PsiOxus Therapeutics, Ltd. (PsiOxus), a new, development stage biotechnology company using non-traditional approaches to novel therapeutics for cancer and wasting diseases.
Date:
Wednesday 15th December 2010
Categories:
Medical and Dental Sciences, Research
Wednesday 10th November 2010

University of Birmingham and Abingdon Health launch medical diagnostics joint venture

Description
The University of Birmingham and medical diagnostics specialists, Abingdon Health Ltd, announce the launch of Bioscience Ventures Limited ("Bioscience Ventures"), a new joint venture aimed at developing and marketing new diagnostics products for the healthcare and other industries.
Date:
Wednesday 10th November 2010
Categories:
Life and Environmental Sciences
Displaying 21 to 24 of 25
Previous 3 4 5 6 7 Next